ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$95.6M |
| 2 |
TWOU
2U Inc
TWOU
|
+$43.5M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$43M |
| 4 |
Nutanix
NTNX
|
+$42.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$29.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$97.5M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$52.6M |
| 3 |
Baidu
BIDU
|
+$47.6M |
| 4 |
LendingTree
TREE
|
+$44.9M |
| 5 |
NVIDIA
NVDA
|
+$36.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.31% |
| 2 | Technology | 26.14% |
| 3 | Communication Services | 11.17% |
| 4 | Financials | 10.19% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
MediWound
MDWD
$185M
| $325K | 0.01% |
+13,728
| New | +$424K |
|
|
CEL
152
DELISTED
Cellcom Israel, Ltd.
CEL
| $319K | 0.01% |
110,305
+25,328
| +30% | +$97.8K |
|
153
Teva Pharmaceuticals
TEVA
$40.2B
| $318K | 0.01% |
34,407
+9,945
| +41% | +$120K |
|
154
Thermo Fisher Scientific
TMO
$212B
| $263K | 0.01% |
+897
| New | +$247K |
|
155
MSCI
MSCI
$41.2B
| $143K | ﹤0.01% |
597
-186
| -24% | -$41.7K |
|
|
FISV
156
Fiserv Inc
FISV
$27.8B
| $98K | ﹤0.01% |
1,078
-795
| -42% | -$69.7K |
|
|
AKE
157
DELISTED
SAFETY FIRST TR PRIN PRO CTFS LKD TO GLBL IND BASKET
AKE
| $90K | ﹤0.01% |
+960
| New | +$90K |
|
|
OPRA
158
Opera Ltd
OPRA
$1.76B
| $77K | ﹤0.01% |
7,342
-3,150
| -30% | -$30K |
|
159
Hexcel
HXL
$7.92B
| $61K | ﹤0.01% |
757
-5
| -0.7% | -$363 |
|
160
Avient
AVNT
$3.91B
| $54K | ﹤0.01% |
1,720
+212
| +14% | +$5.94K |
|
161
Xerox
XRX
$424M
| $53K | ﹤0.01% |
1,489
-532
| -26% | -$17.8K |
|
162
ATI
ATI
$31.3B
| $50K | ﹤0.01% |
1,983
+85
| +4% | +$2.07K |
|
163
Kodak
KODK
$930M
| $50K | ﹤0.01% |
20,712
+5,643
| +37% | +$14K |
|
164
Carpenter Technology
CRS
$28.5B
| $49K | ﹤0.01% |
1,018
-90
| -8% | -$4.24K |
|
165
Eastman Chemical
EMN
$8.49B
| $48K | ﹤0.01% |
616
+26
| +4% | +$1.98K |
|
166
Visa
V
$684B
| $39K | ﹤0.01% |
223
| – | – |
|
|
SGL
167
DELISTED
STRATEGIC GLOBAL INCOME FUND
SGL
| $38K | ﹤0.01% |
+5,553
| New | +$38K |
|
168
DuPont de Nemours
DD
$19.7B
| $32K | ﹤0.01% |
335
+11
| +3% | +$1.31K |
|
|
BAYN
169
DELISTED
BAY NATIONAL CORPORATION
BAYN
| $27K | ﹤0.01% |
+390
| New | +$27K |
|
170
Workday
WDAY
$41.5B
| $19K | ﹤0.01% |
92
-106
| -54% | -$21.4K |
|
|
SAND
171
DELISTED
Sandstorm Gold
SAND
| $16K | ﹤0.01% |
+2,813
| New | +$15.1K |
|
172
Corteva
CTVA
$51.3B
| $12K | ﹤0.01% |
+421
| New | +$11.3K |
|
|
EVK
173
DELISTED
Ever-Glory International Group, Inc.
EVK
| $5K | ﹤0.01% |
+1,621
| New | +$5.68K |
|
|
DSM
174
BNY Mellon Strategic Municipal Bond Fund
DSM
$290M
| $4K | ﹤0.01% |
+445
| New | +$3.5K |
|
175
KLA
KLAC
$255B
| – | – |
-21,440
| Closed | -$248K |
|
Similar funds
ARK Investment Management's Q2 2019 Portfolio in Review
As of Q2 2019, ARK Investment Management held 232 positions worth $3.97B, up 13% from $3.5B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
ARK Investment Management's Q2 2019 filing shows 36 new, 86 increased, 79 reduced and 25 closed positions. Its largest new stake was Meta Platforms (Facebook): 162,707 shares worth $31.4M. The largest sale was Medidata Solutions, Inc., an estimated $97.5M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Communication Services.
- ARK Investment Management's largest Q2 2019 buy was Meta Platforms (Facebook): 162,707 shares worth $31.4M.
- ARK Investment Management added most to Tesla in Q2 2019, an estimated $95.6M increase.
- ARK Investment Management's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $97.5M.
- ARK Investment Management fully exited Zuora, Inc. in Q2 2019, selling an estimated $7.17M.
- ARK Investment Management's ten largest holdings make up 50% of its $3.97B portfolio in Q2 2019.
- ARK Investment Management opened 36 new positions and closed 25 in Q2 2019.
- ARK Investment Management's portfolio value rose 13% quarter-over-quarter to $3.97B.
Based on ARK Investment Management's 13F filing for Q2 2019, filed 30 Jul 2019.